title: Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
authors.affiliation: Department of Psychiatry, Hokkaido Univerisity School of Medicine, Sapporo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Inoue
authors.forename: K
authors.initials: K
authors.lastname: Tsuchiya
authors.forename: J
authors.initials: J
authors.lastname: Miura
authors.forename: S
authors.initials: S
authors.lastname: Sakakibara
authors.forename: K
authors.initials: K
authors.lastname: Denda
authors.forename: T
authors.initials: T
authors.lastname: Kasahara
authors.forename: T
authors.initials: T
authors.lastname: Koyama
mesh_terms: D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage*; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage*; D001971:Bromocriptine / Q000008:administration & dosage*; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D018491:Dopamine Agonists / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010343:Patient Admission; D010555:Personality Inventory; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D018491:Dopamine Agonists; D001971:Bromocriptine